In its third big licensing deal of the week, Eli Lilly has tapped RNA-editing specialist Ascidian for kidney disease therapies in a $1.9bn alliance.
UK offers meningitis jab to young people after outbreak
The UK government has responded to calls to broaden vaccinations for meningitis B, offering the jab to “thousands” of young people this summer.
